Cargando…
Artist® Tablets (Carvedilol) for Hypertensive Patients in Japan: Results of a Long-Term Special Survey
Background: In Japan, when pharmaceutical companies launch a new drug, they are obligated to conduct a post-marketing survey to evaluate the safety and efficacy of the drug in accordance with Good Post-Marketing Surveillance Practice under Article 14-4 (re-examination) of the Pharmaceutical Affairs...
Autores principales: | Iizuka, Tomoko, Nishikawa, Yasuhiro, Mori, Yoshihiro, Zenimura, Natsuko, Matsumoto, Takuyuki, Hiramatsu, Katsutoshi, Komiya, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585767/ https://www.ncbi.nlm.nih.gov/pubmed/21679008 http://dx.doi.org/10.2165/11592460-000000000-00000 |
Ejemplares similares
-
Artist® Tablets (Carvedilol) for Hypertensive Patients in Japan: Results of a Drug Use Survey
por: Mori, Yoshihiro, et al.
Publicado: (2012) -
Inhibitory Effects of Azelnidipine Tablets on Morning Hypertension
por: Kario, Kazuomi, et al.
Publicado: (2013) -
Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study
por: Saito, Ikuo, et al.
Publicado: (2013) -
Development and Validation of New Discriminative Dissolution Method for Carvedilol Tablets
por: Raju, V., et al.
Publicado: (2011) -
Development and optimization of carvedilol orodispersible tablets: enhancement of pharmacokinetic parameters in rabbits
por: Aljimaee, Yazeed HM, et al.
Publicado: (2015)